Current Neuro-Oncology
Volume
25 Number 6
31 March 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 6, 31 March
Huang-Hobbs E, Cheng YT, Ko Y, Luna-Figueroa E, Lozzi B, Taylor
KR, McDonald M, He P, Chen HC, Yang Y, Maleki E, Lee ZF, Murali S,
Williamson M, Choi D, Curry R, Bayley J, Woo J, Jalali A, Monje M,
Noebels JL, Harmanci AS, Rao G, Deneen B.
Remote
neuronal activity drives glioma infiltration via Sema4f.
bioRxiv
[Preprint]. 2023 Mar 16:2023.03.15.532832∟.
doi: 10.1101/2023.03.15.532832∟.
PMID: 36993539∟.
Laboratory
investigation. ˍ
Lavrador JP, Reisz Z, Sibtain N, Rajwani K, Baig Mirza A, Vergani
F, Gullan R, Bhangoo R, Ashkan K, Bleil C, Zebian B, Clark B,
Laxton R, King A, Bodi I, Al-Saraj S.
H3
G34-mutant high-grade gliomas: integrated clinical, imaging and
pathological characterisation of a single-centre case series.
Acta
Neurochir (Wien). 2023 Mar 16∟.
doi: 10.1007/s00701-023-05545-2∟.
PMID: 36929449∟.
Observational study˰ ˍ
Quach S, Schwartz C, Aumiller M, Foglar M, Schmutzer M,
Katzendobler S, El Fahim M, Forbrig R, Bochmann K, Egensperger R,
Sroka R, Stepp H, Rühm A, Thon N.
Interstitial
photodynamic therapy for newly diagnosed glioblastoma.
J
Neurooncol. 2023 Mar 16∟.
doi: 10.1007/s11060-023-04284-9∟.
PMID: 36928699∟.
Observational study. ˍ
Sang H, Cho YK, Han K, Koh EH.
Impact
of abdominal obesity on the risk of glioma development in patients
with diabetes: A nationwide population-based cohort study in
Korea.
PLoS One. 2023
Mar 16;18(3):e0283023∟.
doi: 10.1371/journal.pone.0283023∟.
PMID: 36928679∟.
Observational study. ˍ
°
Yuan J, Xu L, Chien CY, Yang Y, Yue Y, Fadera S, Stark AH,
Schwetye KE, Nazeri A, Desai R, Athiraman U, Chaudhuri AA, Chen H,
Leuthardt EC.
First-in-human
prospective trial of sonobiopsy in glioblastoma patients using
neuronavigation-guided focused ultrasound.
medRxiv
[Preprint]. 2023 Mar 18:2023.03.17.23287378∟.
doi: 10.1101/2023.03.17.23287378∟.
PMID: 36993173∟.
Interventional
study. ˍ
°
Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark
TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M,
Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry
T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim
TS, Marienhagen K, Humberset Ø, Bergström P, Agrup M,
Dahl L, Gubanski M, Gojon H, Brahme CJ, Rydén I, Jakola AS,
Vik-Mo EO, Lie HC, Asphaug L, Hervani M, Kristensen I, Rueegg CS,
Olsen IC, Ledal RJ, Degsell E, Werlenius K, Blomstrand M, Brandal
P.
Investigating survival, quality of
life and cognition in PROton versus photon therapy for IDH-mutated
diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled
trial in Norway and Sweden.
BMJ
Open. 2023 Mar 20;13(3):e070071∟.
doi: 10.1136/bmjopen-2022-070071∟.
PMID: 36940951∟.
Interventional study. ˍ
*
Grogan PT, Helgager JJ, Deming DA, Howard SP, Jenkins RB, Robins
HI.
Case report: Radiographic complete
response of radiation-induced glioblastoma to front-line
radiotherapy: A report and molecular characterization of two
unique cases.
Front
Neurol. 2023 Mar 21;14:1099424∟.
doi: 10.3389/fneur.2023.1099424∟.
PMID: 37025206∟.
Case report. ˍ
Cepeda S, Luppino LT, Pérez-Núñez A, Solheim
O, García-García S, Velasco-Casares M, Karlberg A,
Eikenes L, Sarabia R, Arrese I, Zamora T, Gonzalez P,
Jiménez-Roldán L, Kuttner S.
Predicting
Regions of Local Recurrence in Glioblastomas Using Voxel-Based
Radiomic Features of Multiparametric Postoperative MRI.
Cancers
(Basel). 2023 Mar 22;15(6):1894∟.
doi: 10.3390/cancers15061894∟.
PMID: 36980783∟.
Observational
study. ˍ
Greenhall GHB, Rous BA, Robb ML, Brown C, Hardman G, Hilton RM,
Neuberger JM, Dark JH, Johnson RJ, Forsythe JLR, Tomlinson LA,
Callaghan CJ, Watson CJE.
Organ
Transplants From Deceased Donors With Primary Brain Tumors and
Risk of Cancer Transmission.
JAMA
Surg. 2023 Mar 22:e228419∟.
doi: 10.1001/jamasurg.2022.8419∟.
PMID: 36947028∟.
Observational study. ˍ
Li PJ, Lai SZ, Jin T, Ying HJ, Chen YM, Zhang P, Hang QQ, Deng H,
Wang L, Feng JG, Chen XZ, Guo P, Chen M, Tian Y, Chen
YY.
Radiotherapy opens the blood-brain
barrier and synergizes with anlotinib in treating
glioblastoma.
Radiother
Oncol. 2023 Mar 22:109633∟.
doi: 10.1016/j.radonc.2023.109633∟.
PMID: 36963438∟.
Laboratory investigation˰
ˍ
Oraee-Yazdani S, Akhlaghpasand M, Rostami F, Golmohammadi M,
Tavanaei R, Shokri G, Hafizi M, Oraee-Yazdani M, Zali AR,
Soleimani M.
Case report: Stem
cell-based suicide gene therapy mediated by the herpes simplex
virus thymidine kinase gene reduces tumor progression in
multifocal glioblastoma.
Front
Neurol. 2023 Mar 22;14:1060180∟.
doi: 10.3389/fneur.2023.1060180∟.
PMID: 37034076∟.
Case report. ˍ
Hedrich C, Gojo J, Azizi A, Peyrl A, Slavc I, Winter F, Czech T,
Dorfer C.
Placement of EVD in pediatric
posterior fossa tumors: safe and efficient or old-fashioned? The
Vienna experience.
Childs
Nerv Syst. 2023 Mar 23∟.
doi: 10.1007/s00381-023-05917-0∟.
PMID: 36951979∟.
Observational
study. ˍ
Marak JR, Narayan S, Harsha G, Kaif M.
Primary
glioblastoma of cerebellopontine angle: The diagnostic dilemma of
this rare case.
Radiol
Case Rep. 2023 Mar 23;18(5):2005-2010∟.
doi: 10.1016/j.radcr.2023.02.042∟.
PMID: 37006833∟.
Case report. ˍ
Villani V, Casini B, Tanzilli A, Lecce M, Rasile F, Telera S, Pace
A, Piludu F, Terrenato I, Rollo F, De Nicola F, Fanciulli M,
Pallocca M, Ciliberto G, Carosi M. The
Glioma-IRE project - Molecular profiling in patients with glioma:
steps toward an individualized diagnostic and therapeutic
approach.
J
Transl Med. 2023 Mar 23;21(1):215∟.
doi: 10.1186/s12967-023-04057-y∟.
PMID: 36959606∟.
Observational study. ˍ
Wang M, Yu J, Zhang J, Pan Z, Chen J.
Intraoperative
ultrasound in recurrent gliomas surgery: Impact on residual tumor
volume and patient outcomes.
Front
Oncol. 2023 Mar 23;13:1161496∟.
doi: 10.3389/fonc.2023.1161496∟.
PMID: 37035181∟.
Observational study. ˍ
Moss RM, Sorajja N, Mills LJ, Moertel CL, Hoang TT, Spector LG,
Largaespada DA, Williams LA.
Sex
differences in methylation profiles are apparent in
medulloblastoma, particularly among SHH tumors.
Front
Oncol. 2023 Mar 24;13:1113121∟.
doi: 10.3389/fonc.2023.1113121∟.
PMID: 37035203∟.
Laboratory investigation. ˍ
Nagase T, Ishida J, Sasada S, Sasaki T, Otani Y, Yabuno S, Fujii
K, Uneda A, Yasuhara T, Date I.
IDH-mutant
Astrocytoma Arising in the Brainstem with Symptom Improvement by
Foramen Magnum Decompression: A Case Report.
NMC Case
Rep J. 2023 Mar 24;10:75-80∟.
doi: 10.2176/jns-nmc.2022-0159∟.
PMID: 37065877∟.
Case report. ˍ
Santellan-Hernandez JO, Alvarez-Castro JA, Aguilar-Hidalgo KM,
Soto FC, Escalante JR, Ichikawa-Escamilla E, Silva MJA,
Mejia-Perez SI.
Multifocal glioblastoma
and hormone replacement therapy in a transgender female.
Surg
Neurol Int. 2023 Mar 24;14:106∟.
doi: 10.25259/SNI_104_2023∟.
PMID: 37025534∟.
Case report. ˍ
Yuan Y, Qiu T, Chong ST, Hsu SP, Chu YH, Hsu YC, Xu G, Ko YT, Kuo
KT, Yang Z, Zhu W, Lin CP, Song J.
Automatic
bundle-specific white matter fiber tracking tool using diffusion
tensor imaging data: A pilot trial in the application of
language-related glioma resection.
Front
Oncol. 2023 Mar 24;13:1089923∟.
doi: 10.3389/fonc.2023.1089923∟.
PMID: 37035157∟.
Interventional study. ˍ
Lad BM, Beniwal AS, Jain S, Shukla P, Jung J, Shah SS, Yagnik G,
Babikir H, Nguyen AT, Gill S, Young JS, Lui A, Salha D, Diaz A,
Aghi MK.
Glioblastoma induces the
recruitment and differentiation of hybrid neutrophils from skull
bone marrow.
bioRxiv
[Preprint]. 2023 Mar 25:2023.03.24.534105∟.
doi: 10.1101/2023.03.24.534105∟.
PMID: 36993266∟.
Laboratory investigation. ˍ
Ringel A, Elhasid R, Constantini S, Roth J, Dvir R.
Significant
response to targeted treatment with alectinib for intramedullary
pediatric spinal high-grade glioma with ALK fusion.
Pediatr
Blood Cancer. 2023 Mar 25:e30312∟.
doi: 10.1002/pbc.30312∟.
PMID: 36965191∟.
Authorea
[Preprint].
February 13, 2023∟.
doi: 10.22541/au.167627526.63609485/v1∟.
Case report˰ ˍ
Troschel FM, Troschel BO, Kloss M, Troschel AS, Pepper NB,
Wiewrodt RG, Stummer W, Wiewrodt D, Theodor Eich H.
Cervical
body composition on radiotherapy planning computed tomography
scans predicts overall survival in glioblastoma patients.
Clin
Transl Radiat Oncol. 2023 Mar 27;40:100621∟.
doi: 10.1016/j.ctro.2023.100621∟.
PMID: 37008514∟.
Observational study. ˍ
Leblond P, Tresch-Bruneel E, Probst A, Néant N, Solas C,
Sterin A, Boulanger T, Aerts I, Faure-Conter C, Bertozzi AI,
Chastagner P, Entz-Werlé N, De Carli E, Deley ML, Bouche G,
André N.
Phase I Study of a
Combination of Fluvastatin and Celecoxib in Children with
Relapsing/Refractory Low-Grade or High-Grade Glioma
(FLUVABREX).
Cancers
(Basel). 2023 Mar 28;15(7):2020∟.
doi: 10.3390/cancers15072020∟.
PMID: 37046681∟.
Interventional study. ˍ
Aymeric A, Louis-Marie T, Gabrielle C, Vincent J, Benoit M,
Romuald S, Evelyne E, Luc B, Vincent R, Jimmy V, Christophe J,
Emmanuel M, Leslie L, Bertrand M, Pierre-Jean LR, Andres C,
Antoine P, Valérie R, Karima M, Audrey R, Philippe M,
Dominique FB, Guillaume G, Kaissar F, Johan P, Ilyess Z.
Natural
history of spinal cord metastasis from brain glioblastomas.
J
Neurooncol. 2023 Mar 29∟.
doi: 10.1007/s11060-023-04298-3∟.
PMID: 36991306∟.
Observational
study˰ ˍ
El-Hemaly A, El-Ayadi M, Ahmed S, Taha H, Said M, Refaat A, Ammar
H, Maher E, Badawy E, Reda M, El-Beltagy M, Zaghloul MS, El-Haddad
A.
Prognostic factors affecting
infantile medulloblastoma outcomes in the molecular era: a 12-year
single-center experience from Egypt.
Future
Oncol. 2023 Mar 29∟.
doi: 10.2217/fon-2022-0559∟.
PMID: 36987975∟.
Observational study˰ ˍ
Quan G, Wang T, Ren JL, Xue X, Wang W, Wu Y, Li X, Yuan
T.
Prognostic and predictive impact of
abnormal signal volume evolution early after chemoradiotherapy in
glioblastoma.
J
Neurooncol. 2023 Mar 29∟.
doi: 10.1007/s11060-023-04299-2∟.
PMID: 36991305∟.
Observational
study˰ ˍ
Zha B, Yang J, Dang Q, Li P, Shi S, Wu J, Cui H, Huangfu L, Li Y,
Yang D, Zheng Y.
A phase I clinical
trial of sonodynamic therapy combined with temozolomide in the
treatment of recurrent glioblastoma.
J Neurooncol.
2023 Mar 29∟.
doi: 10.1007/s11060-023-04292-9∟.
PMID: 36988745∟.
Interventional
study˰ ˍ
Khatchadourian C, Guo J, Prasad CJ, Orlando RA, Parsa C.
Report
of multiple high-grade gliomas in two patients with shared
retained ATRX, wild-type IDH, losses of CDKN2A genes and
alterations in the PTEN-PI3K axis.
J
Surg Case Rep. 2023 Mar 30;2023(3):rjad139∟.
doi: 10.1093/jscr/rjad139∟.
PMID: 37008737∟.
Case report. ˍ
Lygina E, Morgacheva D, Khadela A, Postwala H, Shah Y, Dinikina
Y.
Effectiveness of metronomic
chemotherapy in a child with medulloblastoma: A case report.
Oncol
Lett. 2023 Mar 30;25(5):194∟.
doi: 10.3892/ol.2023.13780∟.
PMID: 37113402∟.
Case report. ˍ
Thompson EM, Landi D, Brown MC, Friedman HS, McLendon R, Herndon
JE 2nd, Buckley E, Bolognesi DP, Lipp E, Schroeder K, Becher OJ,
Friedman AH, McKay Z, Walter A, Threatt S, Jaggers D, Desjardins
A, Gromeier M, Bigner DD, Ashley DM.
Recombinant
polio-rhinovirus immunotherapy for recurrent paediatric high-grade
glioma: a phase 1b trial.
Lancet
Child Adolesc Health. 2023 Mar 30∟.
doi: 10.1016/S2352-4642(23)00031-7∟.
PMID: 37004712∟.
Interventional study˰ ˍ
Zhou J, Shi LF, Wang Z, Li M, Zhang JS, Mao Y, Hua W.
OLIG2
expression level could be used as an independent prognostic factor
for patients with cerebellar Glioblastoma (cGBM).
Clinics
(Sao Paulo). 2023 Mar 30;78:100120∟.
doi: 10.1016/j.clinsp.2022.100120∟.
PMID: 37001387∟.
Observational study. ˍ
Baqai
MWS, Aziz HF, Qazi SS, Faisal KS, Shah SMI.
Glioblastoma
imitating a cavernoma radiologically: A unique image report.
Surg
Neurol Int. 2023 Mar 31;14:112∟.
doi: 10.25259/SNI_976_2022∟.
PMID: 37151445∟.
Case
report. ˍ
Lai M, Li S, Li H, Hu Q, Li J, Zhou J, Ai R, Zhen J, Zhou Z, Wang
L, Zhang Y, Hu W, Yuan L, Ma X, Zhang X, Song C, Li Z, Cai
L.
Lorlatinib for ALK-fused,
infant-type hemispheric glioma with lung metastasis: a case
report.
Ann Clin Transl
Neurol. 2023 Mar 31∟.
doi: 10.1002/acn3.51766∟.
PMID: 37000961∟.
Case report. ˍ
Luo C, Yang J, Liu Z, Jing D.
Predicting
the recurrence and overall survival of patients with glioma based
on histopathological images using deep learning.
Front
Neurol. 2023 Mar 31;14:1100933∟.
doi: 10.3389/fneur.2023.1100933∟.
PMID: 37064206∟.
Observational study. ˍ
Sangtongjaraskul S, Sae-Phua V, Amornfa J, Tuchinda L.
Risk
factors of intraoperative blood transfusion in pediatric
craniotomy for intracranial tumor resection: a 10-year analysis.
J
Neurosurg Pediatr. 2023 Mar 31:1-9∟.
doi: 10.3171/2023.2.PEDS22535∟.
PMID: 37021754∟.
Observational
study˰ ˍ
Werlenius K, Kinhult S, Solheim TS, Magelssen H, Löfgren D,
Mudaisi M, Hylin S, Bartek J Jr, Strandéus M, Lindskog M,
Rashid HB, Carstam L, Gulati S, Solheim O, Bartek J, Salvesen Ø,
Jakola AS.
Effect of Disulfiram and
Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in
Patients With Recurrent Glioblastoma: A Randomized Clinical
Trial.
JAMA Netw Open.
2023 Mar 31;6(3):e234149∟.
doi: 10.1001/jamanetworkopen.2023.4149∟.
PMID: 37000452∟.
Interventional study. ˍ
Zhang D, Fan T, Fan W, Zhao X, Liang C, Wang Y, Wu K.
Clinical
Characteristics and Treatment Outcomes of Long-Level
Intramedullary Spinal Cord Tumors: A Consecutive Series of 43
Cases.
Neurospine.
2023 Mar 31;20(1):231-239∟.
doi: 10.14245/ns.2244648.324∟.
PMID: 37016869∟.
Observational study. ˍ